Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maan Hasso

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Influenza and Other Respiratory Viruses|March 5, 2026
Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in CanadaLea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2024
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)Danuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulationDanuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|October 10, 2024
Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021-September 2023Venkata Duvvuri, Fatima Shire, Sandra Isabel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 6, 2026
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026Lea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Emerging Infectious Diseases|October 12, 2022
Monkeypox Virus Detection in Different Clinical Specimen TypesMaan Hasso, Stephen Perusini, Alireza Eshaghi, et al.
Open Forum Infectious Diseases|February 23, 2024
Longitudinal Analysis of Mpox Virus DNA Detectability From Multiple Specimen Types During Acute Illness: A Cohort StudyDarrell H S Tan, Oscar Pico Espinosa, John Matelski, et al.
Npj Viruses|April 28, 2025
Inferring enterovirus D68 transmission dynamics from the genomic data of two 2022 North American outbreaksMartin Grunnill, Alireza Eshaghi, Lambodhar Damodaran, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Influenza and Other Respiratory Viruses|March 5, 2026
Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID-19 in CanadaLea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2024
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)Danuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulationDanuta M Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|October 10, 2024
Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021-September 2023Venkata Duvvuri, Fatima Shire, Sandra Isabel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 6, 2026
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026Lea Separovic, Suzana Sabaiduc, Yuping Zhan, et al.
Emerging Infectious Diseases|October 12, 2022
Monkeypox Virus Detection in Different Clinical Specimen TypesMaan Hasso, Stephen Perusini, Alireza Eshaghi, et al.
Open Forum Infectious Diseases|February 23, 2024
Longitudinal Analysis of Mpox Virus DNA Detectability From Multiple Specimen Types During Acute Illness: A Cohort StudyDarrell H S Tan, Oscar Pico Espinosa, John Matelski, et al.
Npj Viruses|April 28, 2025
Inferring enterovirus D68 transmission dynamics from the genomic data of two 2022 North American outbreaksMartin Grunnill, Alireza Eshaghi, Lambodhar Damodaran, et al.
Pageof 2